Circulating fibrocytes as a new tool to predict lung cancer progression after surgery?

Pauline Henrot; Fabien Beaufils; Matthieu Thumerel; Edmée Eyraud; Augustin Boudoussier; Hugues Begueret; Elise Maurat; Pierre-Olivier Girodet; Roger Marthan; Patrick Berger; Isabelle Dupin; Maéva Zysman

doi:10.1183/13993003.01221-2021

Circulating fibrocytes as a new tool to predict lung cancer progression after surgery?

Eur Respir J. 2021 Dec 9;58(6):2101221. doi: 10.1183/13993003.01221-2021. Print 2021 Dec.

Authors

Pauline Henrot^{1

2

3

4}, Fabien Beaufils^{1

2

3

4}, Matthieu Thumerel^{1

2

3

4}, Edmée Eyraud^{1

2}, Augustin Boudoussier³, Hugues Begueret³, Elise Maurat^{1

2}, Pierre-Olivier Girodet^{1

2

3}, Roger Marthan^{1

2

3}, Patrick Berger^{1

2

3}, Isabelle Dupin^{1

2}, Maéva Zysman^{5

2

3}

Affiliations

¹ Univ-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, INSERM U1045, Pessac, France.
² Inserm, Centre de Recherche Cardio-thoracique de Bordeaux, U 1045 & CIC 1401, Pessac, France.
³ CHU de Bordeaux, Hôpital du Haut-Lévêque, Services des Maladies Respiratoires, Explorations Fonctionnelles Respiratoires, Anatomopathologie & Chirurgie Thoracique, Pessac, France.
⁴ Co-first authors.
⁵ Univ-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, INSERM U1045, Pessac, France maeva.zysman@chu-bordeaux.fr.

PMID: 34561289
DOI: 10.1183/13993003.01221-2021

No abstract available

Publication types

Letter

MeSH terms

Fibroblasts / pathology
Humans
Lung / pathology
Lung Neoplasms* / diagnosis
Lung Neoplasms* / pathology
Pulmonary Fibrosis* / pathology

Associated data

ClinicalTrials.gov/NCT01692444